חיפוש
170 מחקרים תואמים למסננים אלה. מציג 26–50 מתוך 170 מחקרים
| מספר רישום | מחקר | מצב | שלב | גיוס | אתרים / מדינות | שנת התחלה | עודכן לאחרונה | פעולות |
|---|---|---|---|---|---|---|---|---|
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 1,142 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 11,800יעד | 1,142 / 51 | 2025 | 12 בנוב׳ 2026 | |
| NCT06424288 | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empag… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 672 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 6,712יעד | 672 / 30 | 2024 | 12 בנוב׳ 2026 | |
| NCT07415031 | A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorect… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 101 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 2 | 170יעד | 101 / 21 | 2026 | 12 בנוב׳ 2026 | |
| NCT07516444 | VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial) Pivotal trial to evaluate the safety and clinical efficacy of the VDyne TriNova System for the treatment of symptomatic severe or greater tricuspid regurgitation. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 12 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | לא רלוונטי | 520יעד | 12 / 1 | 2026 | 10 בנוב׳ 2026 | |
| NCT06561386 | A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1% ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 330 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 1,000יעד | 330 / 31 | 2024 | 9 בנוב׳ 2026 | |
| NCT03723928 | S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as t… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 723 מרכזים בסך הכול | מגייס | לא רלוונטי | 739יעד | 723 / 3 | 2018 | 9 בנוב׳ 2026 | |
| NCT06215716 | A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The study will enroll subjects in two cohorts for a total samples size of 1650 subjects. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 361 מרכזים בסך הכול | מגייס | שלב 3 | 1,650יעד | 361 / 18 | 2023 | 6 בנוב׳ 2026 | |
| NCT06742723 | A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Hutchinson, Kansas, United States — במרחק 36 ק"מ · 771 מרכזים בסך הכול | מגייס | שלב 3 | 5,000יעד | 771 / 42 | 2025 | 6 בנוב׳ 2026 | |
| NCT03899155 | Pan Tumor Rollover Study Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 410 מרכזים בסך הכול | מגייס | שלב 2 | 1,500יעד | 410 / 38 | 2019 | 6 בנוב׳ 2026 | |
| NCT06915233 | A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle The objective of this study is to demonstrate the superiority of MACI (autologous cultured chondrocytes on porcine collagen membrane) versus Bone Marrow Stimulation in the treatment of patients aged 17 to 65 years with symptomatic articular chondral or osteochondral defects of the talus. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 12 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 309יעד | 12 / 1 | 2026 | 5 בנוב׳ 2026 | |
| NCT07282665 | A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile) vaccine is in decreasing the number of C. difficile infections (pCDI) in adults 65 years of age or older. The participants will receive either the C. difficile vaccine or placeb… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Newton, Kansas, United States — במרחק 53 ק"מ · 185 מרכזים בסך הכול | מגייס | שלב 3 | 32,500יעד | 185 / 4 | 2025 | 5 בנוב׳ 2026 | |
| NCT07353931 | Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight The YDAN master protocol will support two independent studies, J3R-MC-YOA1 and J3R-MC-YOA2. Each study will investigate how well and safely Eloralintide (LY3841136) works in adults with obesity or overweight who have osteoarthritis (OA) of the knee with pain. Participation in the study will last abo… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Newton, Kansas, United States — במרחק 53 ק"מ · 147 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 900יעד | 147 / 13 | 2026 | 4 בנוב׳ 2026 | |
| NCT05174169 | Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 1,085 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 2 / שלב 3 | 1,912יעד | 1,085 / 3 | 2022 | 4 בנוב׳ 2026 | |
| NCT05633654 | Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 378 מרכזים בסך הכול | מגייס | שלב 3 | 1,514יעד | 378 / 12 | 2022 | 4 בנוב׳ 2026 | |
| NCT05080673 | Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps This trial examines colorectal cancer incidence in participants with 1 to 2 non-advanced adenomas randomized to surveillance colonoscopy at 10 years compared to participants randomized to surveillance colonoscopy at 5 and 10 years. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 499 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | לא רלוונטי | 9,500יעד | 499 / 2 | 2022 | 4 בנוב׳ 2026 | |
| NCT05334069 | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 751 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | 2,900יעד | 751 / 1 | 2022 | 4 בנוב׳ 2026 | ||
| NCT07293247 | A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment This phase II trial compares the effect of intensity-modulated post-operative radiation therapy (I²-PORT) followed by standard of care therapy (chemotherapy or immunotherapy) to standard of care therapy alone in treating patients with non-small cell lung cancer (NSCLC) who have remaining lymph node… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 125 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 2 | 164יעד | 125 / 1 | 2026 | 3 בנוב׳ 2026 | |
| NCT06750094 | A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy The purpose of this study is to compare how long the participants are disease-free (progression-free survival) and and the length of time until a participant dies (overall survival), when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovor… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 251 מרכזים בסך הכול | מגייס | שלב 3 | 700יעד | 251 / 26 | 2024 | 3 בנוב׳ 2026 | |
| NCT06662786 | A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, oxaliplatin (mFOLFOX6) or 5-fluorouracil, leucovorin calcium (folini… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 239 מרכזים בסך הכול | מגייס | שלב 3 | 1,000יעד | 239 / 22 | 2024 | 3 בנוב׳ 2026 | |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia This phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a chemotherapy dr… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 460 מרכזים בסך הכול | מגייס | שלב 3 | 303יעד | 460 / 2 | 2017 | 3 בנוב׳ 2026 | |
| NCT07196722 | A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately to severely active Crohn's disease (CD; a long-term condition causing severe inflammation of the intestinal tract). ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 395 מרכזים בסך הכול | מגייס | שלב 2 / שלב 3 | 1,092יעד | 395 / 28 | 2025 | 3 בנוב׳ 2026 | |
| NCT02523014 | Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with meningioma that is growing, spreading, or getting worse (progressive). Vismodegib, FAK inhibitor GSK2256098, capivasertib, and abemaciclib may stop the g… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Kingman, Kansas, United States — במרחק 28 ק"מ · 791 מרכזים בסך הכול | מגייס | שלב 2 | 124יעד | 791 / 1 | 2015 | 3 בנוב׳ 2026 | |
| NCT06319820 | A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC. ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 193 מרכזים בסך הכול | מגייס | שלב 3 | 641יעד | 193 / 20 | 2024 | 3 בנוב׳ 2026 | |
| NCT07321652 | Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL This phase III trial compares the effect of adding sonrotoclax to zanubrutinib versus zanubrutinib alone for the treatment of patients with untreated chronic lymphoblastic leukemia (CLL)/small lymphocytic lymphoma (SLL). Sonrotoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhib… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Kingman, Kansas, United States — במרחק 28 ק"מ · 261 מרכזים בסך הכול · פרטי קשר זמינים | מגייס | שלב 3 | 466יעד | 261 / 1 | 2026 | 3 בנוב׳ 2026 | |
| NCT07225946 | A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer The purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the length of time from start of treatment until disease worsens as determined by scans or death due to any cause) when compared to treatment with docetaxe… ✓ יצירת קשר✗ נתבע המרכז הקרוב ביותר: Wichita, Kansas, United States — במרחק 43 ק"מ · 165 מרכזים בסך הכול | מגייס | שלב 3 | 800יעד | 165 / 17 | 2025 | 3 בנוב׳ 2026 |